Skip to content

Enclomiphene

Enclomiphene (Androxal) is a medicine used for secondary hypogonadism in men. This catalogue lists two tablet formulations of the ingredient, Enclomisign and Androxal.

Enclomisign

Secondary Hypogonadism

50mg

Enclomiphene tablets for low testosterone due to secondary hypogonadism. They stimulate the body's own testosterone production.

From$1.83/ tabletView

Androxal

Secondary Hypogonadism

50mg

Enclomiphene tablets for secondary hypogonadism. Unlike testosterone replacement, it can help preserve fertility in men who wish to remain fertile.

From$1.14/ tabletView

Key points

  • Enclomiphene is a selective oestrogen receptor modulator (SERM) that acts on oestrogen receptors to stimulate hormone release from the pituitary gland.
  • The two formulations come from different manufacturers: Enclomisign is listed by Signature Pharma and Androxal by Repros Therapeutics.
  • Both products are categorised under Hormone Therapy, which covers treatments that address hormonal imbalances in men.

Brands and forms in this catalogue

Enclomisign and Androxal both contain enclomiphene in tablet form. Androxal is the recognised originator brand from Repros Therapeutics, while Enclomisign is a generic line from Signature Pharma. Both products are intended for men with secondary hypogonadism and sit within the Hormone Therapy category.

Further reading